These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
245 related items for PubMed ID: 3261129
21. Treatment of Paget's disease with intermittent low-dose infusions of disodium pamidronate (APD). Stone MD, Hawthorne AB, Kerr D, Webster G, Hosking DJ. J Bone Miner Res; 1990 Dec; 5(12):1231-5. PubMed ID: 2075835 [Abstract] [Full Text] [Related]
22. Treatment of Paget's disease of bone with single dose intravenous pamidronate. Watts RA, Skingle SJ, Bhambhani MM, Pountain G, Crisp AJ. Ann Rheum Dis; 1993 Aug; 52(8):616-8. PubMed ID: 8215628 [Abstract] [Full Text] [Related]
23. Clinical and biological effects of low doses of (3 amino-1 hydroxypropylidene)-1,1-bisphosphonate (APD) in Paget's disease of bone. Heynen G, Delwaide P, Bijvoet OL, Franchimont P. Eur J Clin Invest; 1982 Feb; 12(1):29-35. PubMed ID: 6802650 [No Abstract] [Full Text] [Related]
24. Response of biochemical markers of bone turnover to pamidronate infusion in Paget's disease of bone. Sharp CA, Worsfold M, Rowlands PR, Davie MW. Semin Arthritis Rheum; 1994 Feb; 23(4):242-3. PubMed ID: 8009239 [No Abstract] [Full Text] [Related]
25. Intravenously administered pamidronate in the treatment of Paget's disease of bone. Tucci JR, Bontha S. Endocr Pract; 2001 Feb; 7(6):423-9. PubMed ID: 11747277 [Abstract] [Full Text] [Related]
26. Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate. Adami S, Salvagno G, Guarrera G, Montesanti F, Garavelli S, Rosini S, Lo Cascio V. Calcif Tissue Int; 1986 Oct; 39(4):226-9. PubMed ID: 2947663 [Abstract] [Full Text] [Related]
27. [Amino-hydroxy-propylidene biphosphonate in the treatment of Paget's disease resistant to calcitonin and/or etidronate]. Miravet L, Kuntz D. Rev Rhum Mal Osteoartic; 1989 Mar 15; 56(4):287-92. PubMed ID: 2496460 [Abstract] [Full Text] [Related]
28. Rapid, divergent changes in spinal and forearm bone density following short-term intravenous treatment of Paget's disease with pamidronate disodium. Price RI, Gutteridge DH, Stuckey BG, Kent GN, Retallack RW, Prince RL, Bhagat CI, Johnston CA, Nicholson GC, Stewart GO. J Bone Miner Res; 1993 Feb 15; 8(2):209-17. PubMed ID: 8442439 [Abstract] [Full Text] [Related]
29. Bisphosphonate therapy for Paget's disease in a patient with hypoparathyroidism: profound hypocalcemia, rapid response, and prolonged remission. Stuckey BG, Lim EM, Kent GN, Ward LC, Gutteridge DH. J Bone Miner Res; 2001 Sep 15; 16(9):1719-23. PubMed ID: 11547843 [Abstract] [Full Text] [Related]
30. Single-day intravenous pamidronate in Paget's disease. Hooper MJ, Clifton-Bligh P, Marel GM, Lang FV, Tancred J, McDowall D, Forman L. Semin Arthritis Rheum; 1994 Feb 15; 23(4):276-7. PubMed ID: 8009255 [Abstract] [Full Text] [Related]
31. Treatment of Paget's disease of bone with aminohydroxybutylidene bisphosphonate. O'Doherty DP, Bickerstaff DR, McCloskey EV, Hamdy NA, Beneton MN, Harris S, Mian M, Kanis JA. J Bone Miner Res; 1990 May 15; 5(5):483-91. PubMed ID: 2195845 [Abstract] [Full Text] [Related]
32. Antiresorptive effect of a single infusion of microgram quantities of zoledronate in Paget's disease of bone. Arden-Cordone M, Siris ES, Lyles KW, Knieriem A, Newton RA, Schaffer V, Zelenakas K. Calcif Tissue Int; 1997 May 15; 60(5):415-8. PubMed ID: 9115157 [Abstract] [Full Text] [Related]
33. Paget's disease of bone: benefits of neridonate as a first treatment and in cases of relapse after clodronate. Filipponi P, Cristallini S, Policani G, Casciari C, Gregorio F. Bone; 1998 Dec 15; 23(6):543-8. PubMed ID: 9855463 [Abstract] [Full Text] [Related]
34. Efficacy of the bisphosphonate APD in the control of Paget's bone disease. Mautalen CA, Gonzalez D, Ghiringhelli G. Bone; 1985 Dec 15; 6(6):429-32. PubMed ID: 4096879 [Abstract] [Full Text] [Related]
35. Changes in serum HDL and LDL cholesterol in patients with Paget's bone disease treated with pamidronate. Montagnani A, Gonnelli S, Cepollaro C, Campagna MS, Franci MB, Pacini S, Gennari C. Bone; 2003 Jan 15; 32(1):15-9. PubMed ID: 12584031 [Abstract] [Full Text] [Related]
36. Effects of five daily 1 h infusions of alendronate in Paget's disease of bone. O'Doherty DP, Gertz BJ, Tindale W, Sciberras DG, Survill TT, Kanis JA. J Bone Miner Res; 1992 Jan 15; 7(1):81-7. PubMed ID: 1549961 [Abstract] [Full Text] [Related]
37. Prevention of appendicular bone loss in Paget's disease following treatment with intravenous pamidronate disodium. Stewart GO, Gutteridge DH, Price RI, Ward L, Retallack RW, Prince RL, Stuckey BG, Kent GN, Bhagat CI, Dhaliwal SS. Bone; 1999 Feb 15; 24(2):139-44. PubMed ID: 9951784 [Abstract] [Full Text] [Related]
38. Intravenous pamidronate in Paget's disease--response is dependent on radiographic and biochemical severity. Stuckey BG, Gutteridge DH, Stewart GO, Prince RL, Ward LC, Kent GN, Prince RI, Retallack RW, Bhagat CI, Nicholson GC. Semin Arthritis Rheum; 1994 Feb 15; 23(4):286. PubMed ID: 8009263 [No Abstract] [Full Text] [Related]
39. An evaluation of serum osteocalcin in Paget's disease of bone and its response to diphosphonate treatment. Coulton LA, Preston CJ, Couch M, Kanis JA. Arthritis Rheum; 1988 Sep 15; 31(9):1142-7. PubMed ID: 3048274 [Abstract] [Full Text] [Related]